Important note: Information in this article was accurate in 2006. The state of the art may have changed since the publication date.
The New York Times - October 13, 2006
Then Botswana made a simple change in the rules for AIDS testing that allowed the program to soar. Previously, Botswanans could get tested only after providing written consent and accepting extensive counseling. Now, unless they object, all patients entering a clinic or hospital are routinely given an AIDS test. The rate of testing has quadrupled. A third of Botswanans now know their H.I.V. status, and 85 percent of those who need treatment get it.
The American Centers for Disease Control and Prevention recommended late last month that such routine AIDS testing - called opt-out - become the standard in the United States. This is an important reform. It is even more crucial for poor countries, where 90 percent of those infected do not know it.
UNAIDS and the World Health Organization should move quickly to endorse opt-out AIDS testing. Their guidance is followed worldwide and will help rally needed help from outside donors.
The current protocols for testing - with their strong emphasis on privacy and consent - were designed when little could be done to help people with H.I.V. Now antiretrovirals are being rolled out in every country. But without easy access to testing, people may find out they have AIDS only when it is too late to save their lives. They will also have spent years unknowingly passing on the infection.
Where opt-out testing has been used, few patients decline tests. Treating H.I.V. like any other disease could also help lessen the stigma. People who have been tested before they feel sick also start AIDS treatment earlier, and do better on it. And studies show that those who know their status are only half as likely to infect someone else, when compared with an H.I.V. carrier who is still in the dark.
Governments need to follow Botswana's lead and make AIDS testing routine in every health clinic and hospital. And donors should ensure that every clinic has a reliable supply of AIDS tests.
061013
NYT061008
Copyright © 2006 - The New York Times Company. All Rights Reserved. All New York Times articles contained on the AEGiS web site are protected by United States copyright law and may not be reproduced, distributed, transmitted, displayed, published or broadcast without the prior written permission of The New York Times Company. You may not alter or remove any trademark, copyright or other notice from copies of the content. However, you may download articles (one machine readable copy and one print copy per page) for your personal, noncommercial use only.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .